Ngozi Erondu

14.1k citations
50 papers · 9.6k indexed · 4 hit papers · h-index 30
Topics
Pharmacology and Obesity Treatment (10 papers)Psoriasis: Treatment and Pathogenesis (9 papers)Diabetes Treatment and Management (9 papers)

In The Last Decade

Ngozi Erondu

50 papers receiving 9.3k citations

Hit Papers

Canagliflozin an...1983202619972011201719832018201710002.0k3.0k4.0k5.0k

Peers

Ngozi Erondu
Comparison fields: 5 of 132
  • Endocrinology, Diabetes and Metabolism 6.1k
  • Molecular Biology 3.3k
  • Surgery 2.6k
  • Cardiology and Cardiovascular Medicine 1.4k
  • Pharmacology 1.1k
Replace Morris Schambelan with:
Morris Schambelan United States
Mark C. Chappell United States
Akira Sugawara Japan
Nayyar Iqbal United States
Duncan J. Campbell Australia
Winfried Siffert Germany
Franco Mantero Italy
Debra I. Diz United States
Massimo Federici Italy
Jane E.B. Reusch United States
Ngozi Erondu relative to Morris Schambelan United States Morris Schambelan's profile →
Citations per field
00.5×12×
Morris Schambelan · 1×
Citations per year

Countries citing papers authored by Ngozi Erondu

Since Specialization
Citations

This map shows the geographic impact of Ngozi Erondu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ngozi Erondu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ngozi Erondu more than expected).

Fields of papers citing papers by Ngozi Erondu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ngozi Erondu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ngozi Erondu. The network helps show where Ngozi Erondu may publish in the future.

Co-authorship network of co-authors of Ngozi Erondu

This figure shows the co-authorship network connecting the top 25 collaborators of Ngozi Erondu. A scholar is included among the top collaborators of Ngozi Erondu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ngozi Erondu. Ngozi Erondu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Eventsbreakdown →
375
3 90
4
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetesbreakdown →
5379
5 308
6 59
7 24
8 43
9 78
10 68
11 23
12 165
13 47
14 5
15 73
16 30
17 29
18 23
19 39
20 71

About Ngozi Erondu

Ngozi Erondu is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Endocrine and Autonomic Systems, having authored 50 papers that have together received 9.6k indexed citations. Recurring topics across this work include Pharmacology and Obesity Treatment (10 papers), Psoriasis: Treatment and Pathogenesis (9 papers) and Diabetes Treatment and Management (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.1k citations), Nephrology (796 citations) and Pharmacology (1.1k citations). Ngozi Erondu has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Mehul Desai, Kenneth W. Mahaffey, Bruce Neal, Dick de Zeeuw, Vlado Perkovic, David R. Matthews, Greg Fulcher, Wayne Shaw, Gordon Law and Mary B. Kennedy. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026